卓越新能(688196.SH):擬向銀行申請最高額度不超6億元融資融信業務
格隆匯3月28日丨卓越新能(688196.SH)公佈,公司於2022年3月27日召開第四屆董事會第九次會議,審議通過《關於向銀行申請融資融信業務的議案》,同意公司向銀行申請最高額度不超過人民幣(或等值外幣)6億元的融資融信業務,品種包括:流動資金借款;銀行承兑匯票;國內、外保函和信用證;貼現;貿易融資;保理;融資性保函;外匯交易等信貸業務,擔保方式為信用或等額結構性存款/理財/定期存款做質押擔保。本事項的有效期自本次董事會審議通過之日起十二個月內有效。在有效期內,額度可滾動使用。
公司此次向銀行申請融資融信業務不涉及對外擔保或關聯交易,無需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.